Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes
Status:
Completed
Trial end date:
2017-07-07
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, active-controlled, multicenter phase 3 trial to evaluate the safety
and efficacy of YH14755 in subjects with dyslipidemia and Type II Diabetes.